169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Nanoparticle probes and methods of making and use thereof
#1802INTERACTIVE COMPUTING SYSTEM TO GENERATE CUSTOMIZED PREVENTIVE HEALTH INFORMATION BASED ON AN INDIVIDUAL'S BIOMARKERS
#1803METHODS FOR QUANTIFYING INTER-ALPHA INHIBITOR PROTEINS
#1804Methods of treating patients at risk for renal injury and renal failure
#1805SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#1806Anti-transthyretin antibodies
#1807PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#1808Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1809Markers for renal disease
#1810Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#1811Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response
#1812Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )
#1813Antibodies and methods for the detection of cell death
#1814DIAGNOSTIC METHODS FOR LIVER DISORDERS
#1815HLA G-modified cells and methods
#1816GALECTIN-3 IMMUNOASSAY
#1817SYSTEMS AND METHODS FOR METABOLOME ANALYSIS
#1818Exosome-mediated diagnosis of human immunodeficiency virus infection
#1819Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody
#1820USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#1821METHODS AND DEVICES FOR MULTI-STEP CELL PURIFICATION AND CONCENTRATION
#1822NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY
#1823PLUG-IN EXPERTISE FOR PATHOGEN IDENTIFICATION USING MODULAR NEURAL NETWORKS
#1824Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
#1825Therapeutic agents
#1826Treatment of multiple sclerosis and neuromyelitis optica
#1827METHOD FOR CALCULATING GLOMERULAR FILTRATION RATE (GFR)
#1828Identification and analysis of protein biomarkers
#1829Method of diagnosis of drug induced liver injury
#1830NON-INVASIVE DIAGNOSIS OF FIBROTIC NON-ALCOHOLIC STEATOHEPATITIS
#1831Biodosimetry panels and methods
#1832NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF
#1833Method and Compound for Modifying Circadian Clock
#1834Treatment of circadian rhythm disorders
#1835Exosomal Protein Profiling for Detection of Cardiac Transplant Rejection
#1836Method for Using a Marker Set for Determining the Risk of Kidney Rejection
#1837METHOD AND DEVICE FOR DETECTING SIGLEC12
#1838Cytotoxic T cell response modifiers
#1839Compositions and methods for the removal of biofilms
#1840Fluorogenic glycosidase substrate and associated detection method
#1841QUANTITATIVE METHODS AND KITS FOR PROVIDING REPRODUCIBLE IHC4 SCORES
#1842Tissue-specific exosomes as biomarkers
#1843Methods for treating or predicting risk of a ventricular tachyarrhythmia event
#1844BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE
#1845Biomarkers for the diagnosis of lacunar stroke
#1846DIAGNOSTIC METHOD
#1847Immunochromatographic device, immunochromatographic kit and immunochromatographic detection method
#1848DETECTION AND TREATMENT OF DILATED CARDIOMYOPATHY IN THE DOBERMAN PINSCHER
#1849NEW USES OF ANTI-SIRPg ANTIBODIES
#1850Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1851ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE
#1852Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
#1853Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm
#1854Method of diluting a metred quantity of a test fluid for analysis
#1855CHECK POINT INHIBITION IN ORGAN FIBROSIS
#1856IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#1857Kit and method for detecting porous dental hydroxyapatite
#1858ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF
#1859METABOLIC DISORDERS
#1860System and method for detection of trauma
#1861Diagnostic and prognostic methods for cardiovascular diseases and events
#1862Point-of-care system and method for diagnosing acute febrile illness
#1863NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN
#1864Compositions and methods for treating lysosomal storage diseases and disorders
#1865Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
#1866Preventive or therapeutic agent for kidney disease
#1867Metabolite biomarkers for diseases associated with the contact activation system
#1868ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF
#1869Biomarkers for anti-IL4-IL13 bispecific antibodies
#1870Peptides And Methods For Detecting Peanut Allergies
#1871Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#1872Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
#1873USE OF THE CD71 RECEPTOR IN THE PROGNOSIS AND TREATMENT OF ENDOMETRIOSIS
#1874Compositions and methods for treating chemosensory dysfunction
#1875MASS SPECTROMETRIC STANDARDS FOR HEMOGLOBIN BETA AND HEMOGLOBIN BETA SICKLE AND USES THEREOF
#1876GFAP ACCUMULATING IN STROKE
#1877ASSAYS AND METHODS FOR DETECTION AND TARGETED TREATMENT OF HYDROSALPINX
#1878Exosome-mediated diagnosis of hepatitis virus infections and diseases
#1879PREDICTION OF KIDNEY DISEASE PROGRESSION USING HOMOARGININE AS A BIOMARKER
#1880REDOX PROBING FOR CHEMICAL INFORMATION
#1881ATRIAL FIBRILLATION POLYGENIC RISK SCORE
#1882Method for detecting the risk and prognosis of adult-onset Still's disease
#1883Methods and materials for identifying and treating acute graft-versus-host disease
#1884Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement
#1885Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
#1886Inhibiting the onset of gout
#1887MOLECULAR MARKER AND KIT FOR EARLY DIAGNOSIS AND PREDICTION OF SEPSIS ACUTE KIDNEY INJURY AND APPLICATION THEREOF
#1888Biomarkers for graft-versus-host disease
#1889INSULIN GENE-DERIVED PROTEINS AND PEPTIDES FOR USE IN THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#1890PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#1891Testing and representing suspicion of sepsis
#1892Sepsis infection determination systems and methods
#1893Health test for a broad spectrum of health problems
#1894Thyroglobulin quantitation by mass spectrometry
#1895Fab-linked glycans as biomarker for the transition from a pre-disease “at-risk-phase” to rheumatoid arthritis; AAV or Sjögren syndrome
#1896Multi-array impedimetric biosensors for the detection of concussion and traumatic brain injuries
#1897Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
#1898ANALYSIS AND SORTING OF MOTILE CELLS
#1899Methods of treating inflammatory and autoimmune diseases with natalizumab
#1900HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
#1901Anti-GP73 monoclonal antibodies and methods of obtaining the same
#1902PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION
#1903USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#1904METHOD FOR DISCRIMINATING BETWEEN PROSTATE CANCER AND A BENIGN PROSTATE DISEASE
#1905PROTEINS
#1906METHOD FOR DIAGNOSING COMPLICATED PARAPNEUMONIC EFFUSION
#1907Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
#1908Methods and kits for determining predisposition to develop kidney diseases
#1909NON-POLYAMINATED LCN2 AS A BIOMARKER FOR DIAGNOSIS AND TREATMENT OF CARDIOMETABOLIC DISEASES
#1910FARBER DISEASE MARKERS AND USES THEREOF
#1911Use of leucine-zipper protein for diagnosis or treatment of fatty liver
#1912Method for Measuring Tear Constituents in a Tear Sample
#1913Biomarkers for use in prognosis of mortality in critically ill patients
#1914Compounds, compositions and methods
#1915ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#1916GFAP DERIVATIVES FOR STROKE DIAGNOSTICS
#1917METHOD OF PREDICTING RESPONSIVENESS OF WET AMD PATIENT TO ANTI-VEGF THERAPY
#1918Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and Kawasaki disease
#1919Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications
#1920Diabetes-related biomarkers and treatment of diabetes-related conditions
#1921Biomarker Panel to Identify Patients at Risk for Peri-Implant Osteolysis
#1922NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER
#1923GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS
#1924Methods for diagnosing and treating eosinophilic esophagitis
#1925Human anti-SOD1 antibodies
#1926IGFBP7 for diagnosing diastolic dysfunction
#1927Method of detecting arteriosclerosis
#1928Biomarker SBP1 for early diagnosis of kidney diseases, and use thereof
#1929Systems and methods for characterizing sepsis
#1930USE OF ECM BIOMARKERS FOR DETERMINING THE TREATMENT ONSET WITH NINTEDANIB AND PIRFENIDONE
#1931Methods of prognosis and treatment
#1932BLOOD SAMPLE ANALYSIS METHOD AND SYSTEM, FOR DETERMINING DIABETES
#1933Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases
#1934Identification of unique gene expression profiles in children with regressive autism spectrum disorder (ASD) and Ileocolitis
#1935Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1936BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#1937POLYMORPHISMS FOR PREDICTING TREATMENT RESPONSE TO ANTIPSYCHOTIC DRUGS AND IDENFYING NEW DRUG TARGETS
#1938METHOD FOR MEASUREMENT AND CONTROL OF INTRACULAR VEGF CONCENTRATION
#19393-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#19402-iminobiotin for use in the treatment of brain cell injury
#1941Method of predicting graft versus host disease
#1942USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS
#1943Detection of glucuronidated and 3-bromotyrosine
#1944Methods for treating sarcopenia and muscle injury
#1945Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (NASH)
#1946Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof
#1947METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1948METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS
#1949Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#1950Anti-FcRn antibodies
#1951METHODS FOR DIAGNOSING AND TREATING NEPHROTIC SYNDROME
#1952Serologic assay of liver fibrosis
#1953Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
#1954Early diagnosis of infections
#1955COMPOSITIONS, DEVICES, AND METHODS OF GASTROESOPHAGEAL REFLUX DISEASE SENSITIVITY TESTING
#1956Assay to measure factor Xa inhibitors
#1957METHOD FOR DETERMINING RISKS ASSOCIATED WITH CARDIOVASCULAR DISEASES
#1958Trimethylamine-containing compounds for diagnosis and prediction of disease
#1959Methods of diagnosing endometriosis
#1960Biomarkers For Endometriosis
#1961Procalcitonin for the prognosis of adverse events
#1962Protein activity modification
#1963Protein Damage in Aging and Age-Related Diseases
#1964Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#1965Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
#1966Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
#1967IN VITRO METHOD FOR DIAGNOSING AT EARLY STAGE INTESTINAL ISCHEMIA
#1968Method for the diagnosis of acute pancreatitis (AP) by detection of glycoprotein 2 isoform alpha (GP2A)
#1969METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#1970Biomarker signatures and uses thereof
#1971Signal amplification in lateral flow and related immunoassays
#1972Screening method for candidate substances for active component to prevent or treat at least one disease selected from the group consisting of renal hypofunction, chronic kidney disease and kidney failure
#1973Compositions and methods for measuring NMU and for treatment using anti-NMU agents
#1974METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE
#1975Modulators of telomere disease
#1976Method and device for optical detection of Kawasaki disease and treatment result
#1977DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#1978METHODS AND USES OF MITOFUSINS
#1979Method of monitoring RNase L activity
#1980Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels
#1981Dosing algorithm for complement inhibitor
#1982METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#1983Method for predicting severity and prognosis of cardiovascular disease
#1984GLYCOSYLATED METABOLITES
#1985Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models
#1986DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES
#1987Procedure of predicting type 2 diabetes development through analysis of N-glycans attached to the plasma proteins of a healthy person
#1988Identification and monitoring of cleaved immunoglobulins by molecular mass
#1989Methods for identifying and treating cachexia or pre-cachexia using an inhibitor of rage
#1990METHOD FOR OBTAINING USEFUL DATA FOR THE DIFFERENTIAL DIAGNOSIS OF LIVER FIBROSIS
#1991Method for detecting active tuberculosis
#1992MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#1993Peanut formulations and used thereof
#1994Qualitative predictive method for differential diagnosis of pneumococcal, meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis
#1995BIOMEDICAL MEASURING DEVICES, SYSTEMS, AND METHODS FOR MEASURING PEPTIDE CONCENTRATION TO MONITOR A CONDITION
#1996METHOD OF PREVENTING ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
#1997HISTONES AND/OR PROADM AS MARKERS INDICATING ORGAN DYSFUNCTION
#1998MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS
#1999Methods and algorithms for aiding in the detection of cancer
#2000Antibody to cytolethal distending toxin of Campylobacter jejuni
#2001Method of treating extracellular tissue and vascular calcification and arteriosclerosis
#2002Peanut formulations and uses thereof
#2003Therapeutic intervention for osteoporosis
#2004Diagnostic Test to Exclude Significant Renal Injury
#2005METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER
#2006Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
#2007CIRCULATING ESM-1 (ENDOCAN) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND/OR STROKE
#2008Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery
#2009COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#2010Marker for statin treatment stratification in heart failure
#2011ONE STEP CARDIAC TEST DEVICE
#2012DETECTING SEPSIS
#2013Method of drug design and optimisation utilizing stereochemical mimicry
#2014PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF
#2015Lipopeptides for use in treating liver diseases and cardiovascular diseases
#2016COMPOSITIONS AND METHODS RELATED TO OBSTRUCTIVE SLEEP APNEA
#2017Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
#2018Thyroglobulin quantitation by mass spectroscopy
#2019METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS
#2020Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
#2021Marker for Cancer Prognosis and Methods Related Thereto
#2022COMPEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS
#2023PROTEIN ACTIVITY MODIFICATION
#2024BIOMARKERS OF METHYLGLYOXAL AND RELATED METHODS THEREOF
#2025Measurement of glycoprotein
#2026ZNT8 assays for drug development and pharmaceutical compositions
#2027REGULATORY B CELLS AND THEIR USES
#2028PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER
#2029C5aR INHIBITOR REDUCTION OF URINARY sCD163
#2030Free radical consumption speed information acquisition method and NASH determination method
#2031Methods and kits for the diagnosis and risk stratification of patients with ischemia
#2032Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#2033Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#2034METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#2035Ensemble-decision aliquot ranking
#2036Detection of symmetrical dimethylarginine
#2037Biomarkers for Fatty Liver Disease and Methods Using the Same
#2038Method of treating asthma using an IL-13 antibody
#2039METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#2040DIAGNOSIS OF CARDIOVASCULAR DISEASE
#2041Protein signatures for distinguishing between bacterial and viral infections
#2042PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER
#2043METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#2044Biomarker for the diagnosis of pulmonary hypertension (PH)
#2045Biomarkers for diagnosing post traumatic stress disorder
#2046METHOD OF DETERMINING AUTOPHAGOSOME FLUX AND USES THEREOF
#2047METHOD FOR DETERMINING MORBIDITY TO DIABETES
#2048Identification of unique blood-based gene expression profiles in children with regressive autism spectrum disorder (ASD) and ileocolitis
#2049In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
#2050Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor
#2051TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro
#2052Method for Identifying an Agent for Treating Abnormal Kidney Function
#2053Methods for detecting, diagnosing and treating ulcerative interstitial cystitis
#2054METHOD OF DETECTION OF CLINICALLY SIGNIFICANT POST-PRANDIAL HYPERGLYCEMIA IN NORMOGLYCEMIC PATIENTS
#2055Biomarkers for use in prognosis of mortality in critically ill patients
#2056Methods Of Identifying Anti-Inflammatory Compounds
#2057Immunological reagents
#2058Ceramides for evaluating risk of cardiovascular disease
#2059CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#2060Free Functional Annexin Levels in Plasma as a Biomarker of Cardiovascular Risk
#2061Method of diagnosing arthritis or other joint degrading disease
#2062MASS SPECTROMETRY KIT
#2063METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#2064TISSUE TESTER
#2065Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM
#2066Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)
#2067COMPOSITION FOR DIAGNOSING ALLERGIES TO MITES, METHOD OF DIAGNOSING ALLERGIES TO MITES, AND COMPOSITION FOR PREVENTING OR TREATING ALLERGIES TO MITES
#2068Method of testing for pulmonary hypertension
#2069Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis
#2070Diagnostic for sjorgen's syndrome based on a biomarker
#2071MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA, PREGNANCY, AND THE TORCH COMPLEX
#2072MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING PREGNANCY AND THE TORCH COMPLEX
#2073Medical apparatus for testing for medical conditions including zika and pregnancy
#2074Agents for use in the therapeutic treatment of hyperopia
#2075Assay device measuring viscosity and detecting or measuring a biomaker
#2076DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION
#2077METHOD FOR CHARACTERIZATION OF CELL SPECIFIC MICROVESICLES
#2078Methods and kits
#2079Calcium binding protein, spermatid specific 1, as a biomarker for diagnosis or treatment of stress
#2080Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
#2081OBESITY RISK DIAGNOSIS KIT AND METHOD FOR ANALYZING RISK OF OBESITY ONSET
#2082Medical use of CREG protein
#2083DIAGONSIS AND TREATMENT OF AUTOIMMUNE DISEASES BY TARGETING AUTOIMMUNE-RELATED B CELLS ("ABCS")
#2084METHOD OF DETECTING LC3B EXPRESSION IN EXOSOMES EXTRACTED FROM LIQUID BIOLOGICAL SAMPLES
#2085CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
#2086METHODS AND SYSTEMS FOR DETECTING TISSUE CONDITIONS
#2087Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
#2088NMR methods and systems for the rapid detection of bacteria
#2089Treatment of circadian rhythm disorders
#2090Biomarkers for Cell Therapy
#2091METHODS OF DETECTING AND TREATING AIRWAY INFLAMMATORY DISEASES
#2092Method for detecting nucleosomes containing histone modifications and variants
#2093IL-22BP AS BIOMARKER IN ANTI-TNF-ALPHA-TREATMENTS
#2094Methods of treating volume depletion and kidney injury
#2095SYSTEMS AND METHODS FOR THE DETECTION OF GLYPICAN-1
#2096Screening method
#2097METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS
#2098Methods and compounds for reducing threonyl-tRNA synthetase activity
#2099Immunological reagents
#2100TM4SF1 binding proteins and methods of using same